NZNurten Özkan Zarif

Nurten Özkan Zarif

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nurten Özkan Zarif has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Water Consumption and Hydration Status in Children Living in Hot Climate Conditions

    by Nesibe Kübra Göl, Nurten Özkan Zarif

    Adequate hydration is essential for maintaining physiological homeostasis, thermoregulation, and cognitive performance in children. Children are particularly vulnerable to dehydration due to physiological characteristics and behavioral factors, especially in hot climate conditions. This review aims to summarize current evidence regarding water consumption patterns, hydration status, and health outcomes associated with inadequate hydration in children living in hot climate environments. This study was conducted as a narrative review. A structured literature search was performed using electronic databases including PubMed, Scopus, and Web of Science. Studies evaluating hydration status, water intake, and related health outcomes in pediatric populations were included, and the findings were qualitatively synthesized. Available evidence indicates that a substantial proportion of children do not meet recommended daily water intake levels and frequently experience mild underhydration. Water consumption is often replaced by sugar-sweetened beverages, and environmental factors such as school settings and limited access to drinking water may further contribute to inadequate intake. Heat exposure significantly increases fluid loss and the risk of dehydration, which may lead to adverse health outcomes including electrolyte imbalance, renal stress, and heat-related illnesses. Hydration status is commonly assessed using biomarkers such as urine osmolality and urine specific gravity. Inadequate hydration is a widespread issue among children and is further exacerbated by hot climate conditions. Promoting adequate water intake, improving access to safe drinking water, and implementing public health strategies are essential to reduce dehydration risk and support child health.

  • Open Access

    Non‐Syndromic Congenital Sodium Diarrhoea With a SLC9A3 Gene Variant: A Case Report

    by Hatice Yilmaz Dagli, Nurten Özkan Zarif, Kıymet Çelik, Sema Arayici, Hakan Ongun, Reha Artan, İbrahim İnanç Mendilcioğlu


  • Open Access

    A Rare Cause of Neonatal Salt Wasting Syndrome: Clinical Management of a Case Diagnosed with Pseudohypoaldosteronism Due to a Novel Homozygous Variant in the SCNN1B Gene

    by Berna Singin, Zeynep Donbaloğlu, Ebru Barsal Çetiner, Kürşat Çetin, Nurten Özkan Zarif, Kıymet Çelik, Ercan Mıhçı, Özden Altıok Clark, Hale Tuhan, Mesut Parlak

    Pseudohypoaldosteronism (PHA) is a rare disorder that, if not promptly recognized and treated, can lead to life-threatening hyperkalemia resulting in cardiac arrest and death. Systemic PHA is caused by variants that deactivate the epithelial sodium channel (ENaC) subunits. Management is challenging due to high-dose oral replacement therapy, and patients with systemic PHA require lifelong treatment. Here, we present the clinical course of a newborn diagnosed with PHA at 7 days of age due to severe dehydration, inadequate feeding, vomiting, and lethargy. The patient was found to be homozygous for the variant c.1234dup (p.Glu412Glyfs*39) in exon 8 of the SCNN1B gene. The patient had multiple hospitalizations during follow-up and died at the age of 10 months due to pneumonia. Maintaining a high clinical suspicion for PHA is crucial for initiating treatment and preventing potential cardiac arrest and death in these patients. Further research is needed to determine the significance of such novel mutations in this disease.


  • Early neonatal outcomes in infants of mothers with organ transplantation under immunosuppressive treatment

    by Kıymet Çelik, Sema Arayıcı, Nurten Özkan Zarif, Zeynep Kıhtır, Hakan Ongun, Bülent Aydınlı

    Background. This study aimed to examine early clinical and laboratory findings in infants born to mothers who had organ transplants and received immunosuppressive treatment. Methods. Between 2016 and 2023, the study examined infants of mothers who underwent organ transplantation and were receiving immunosuppressive treatment, and followed at the Department of Neonatology at Akdeniz University. Demographic, clinical, and laboratory characteristics of mothers and infants were recorded. On the first day of life, complete blood count values were examined, as well as potassium levels on the first, third, and seventh days, and creatinine levels on the third and seventh days. The tacrolimus blood level was calculated by taking the average of the tacrolimus blood values of the mother measured during the pregnancy. The infants were evaluated for any potential morbidities caused by intrauterine immunosuppressive drug exposure. Results. The study included 21 mothers (some with multiple pregnancies) and 27 infants. According to the findings of this study, 74% of these infants were born premature, 67% had low birth weight, and all were delivered via cesarean section. Prematurity was associated with the morbidities found in the infants. In the early period, lymphopenia was detected in 37%, neutropenia in 25.9%, thrombocytopenia in 11.1%, hyperkalemia in 18.5%, and creatinine elevation in 7.4%, all of which returned to normal within a few days. There was no significant relationship between maternal tacrolimus blood levels and infant potassium and creatinine levels. Conclusion. Apart from an increased risk of prematurity, low birth weight, and cesarean delivery, no effects were observed in these infants during the early period. However, long-term follow-up is necessary to monitor for any potential morbidities.

  • Challenges in Diagnosis and Treatment of Neonatal Ventriculitis: A Case Report and Systematic Review of Difficult-to-Treat Central Nervous System Infection Resistant to Conventional Therapy

    by Hakan Ongun, Zeynep Kihtir, Nurten Ozkan Zarif, Ozlem Koyuncu Ozyurt, Tugce Tural Kara, Kiymet Celik, Sema Arayici

    Objective Ventriculitis is an example of the increasing global trend in difficult-to-treat infections in neonates caused by pathogens resistant to conventional therapies. This article describes the first use of intravenous and intraventricular tigecycline to treat ventriculitis caused by vancomycin-resistant enterococci in a preterm neonate and systematically review the literature on challenges posed by the definitions, diagnosis, and treatment of neonatal ventriculitis Methods The authors searched PubMed and Internet search engines for “ventriculitis” in the period from 2003 to 2023 restricting the research to “Newborn,” “Human,” “English language,” and “full-text availability.” Results Thirty-seven publications (20 case reports, 6 case series, and 11 research articles) were extracted upon research. Preterm birth, posthemorrhagic ventricular dilatation requiring placement of ventricular access devices, and sepsis preceded neonatal ventriculitis. Infections caused by rare microorganisms, in particular gram-negative bacteria resistant to conventional therapies, predominated in the publications describing the need for a combination of intravenous (IV) and intraventricular (IVT) therapies. Survivors of neonatal ventriculitis developed neurodevelopmental impairments such as hydrocephalus, seizures, motor function, hearing, and vision impairment. Conclusion Clinical suspicion of ventriculitis indicated by subtle signs is key for prompt diagnosis. Effective IV and IVT antibiotics are essential to prevent serious sequelae and mortality. The drug delivery method should be changed if there is no clinical response. This study emphasizes the urgent need for pediatric trials of antibiotics against organisms resistant to other drugs.